Atropine Sulfate companies

  • Report ID: 2535
  • Published Date: May 29, 2025
  • Report Format: PDF, PPT

Companies Dominating the Atropine Sulfate Landscape

    Organizations emphasizing atropine sulfate are gaining limitless exposure in various regions across all nations, thereby contributing to a healthy market landscape. Companies such as C²PHARMA and Seqens are leading with higher production values of atropine sulfate hydrate that can be adopted by both ophthalmic and emergency medicine conditions. Besides, organizations being Alchem International and Clearsynth are focusing on a steady supply of affordable APIs. The business landscape of the atropine sulfate market is a blend of product innovation, support from governing bodies, and collaborations to serve the unmet medical needs.

    Here is the list of some prominent players in the global market:

    • C²PHARMA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Seqens
    • Clearsynth
    • Katsura Chemical
    • Cfm Oskar Tropitzsch
    • CarboMer
    • Wuhan Fortuna Chemical
    • IsunPharm
    • Capot Chemical
    • Alchem International Pvt. Ltd.
    • Transo-Pharm USA LLC
    • LGM Pharma
    • Veranova
    • Nuray Chemicals Pvt. Ltd.
    • HRV Global Life Sciences
    • Tenatra Chemie
    • Farmhispania
    • Phytex Australia
    • BOC Sciences
    • Dr. Raju’s Pharma Solutions
    • Somerset Pharma
    • Apotex Corp.

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of atropine sulfate is assessed at USD 430.4 million.

Atropine Sulfate Market size was valued at USD 412.9 million in 2024 and is expected to reach USD 687.8 million by 2037, expanding at around 4.8% CAGR during the forecast period i.e., between 2025-2037.

North America industry is estimated to dominate majority revenue share by 40.8 2037, propelled by presence of some of the key players that are also traditional suppliers of medicinal drugs.

The major players in the market are Meridian Medical Technologies, Inc., Novartis AG, Teligent, C²PHARMA, RESONANCE LABORATORIES, China Resources Double-crane Pharmaceutical Co., Ltd., Albany Molecular Research Inc., Alchem International Pvt. Ltd., Saurav Chemicals Ltd., Wuhan senwayer century chemical Co., Ltd., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos